Dyadic International (DYAI) Change in Taxes (2018 - 2020)
Dyadic International (DYAI) posted Change in Taxes of -$5000.0 for Q4 2020, down 100.99% sequentially from $505616.0 in Q3 2020, and up 27.18% YoY from -$3931.5 in Q1 2020.
Dyadic International (DYAI) Change in Taxes (2018 - 2020) Analysis & Trends
Dyadic International has reported Change in Taxes for 3 years, with the latest figure at -$5000.0 in Q4 2020.
- Quarterly Change in Taxes rose 27.18% year-over-year to -$5000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $500616.0 (changed 0.0% YoY) and the FY2020 annual result came in at $500616.0, changed 0.12% from the prior year.
- Change in Taxes slipped to -$5000.0 in Q4 2020 per DYAI's latest filing, from $505616.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $505616.0 in Q3 2020 and troughed at -$102000.0 in Q1 2018.
- A 3-year average of $187577.0 and a median of $54124.5 in 2018 frame the typical range for Change in Taxes.
- The widest YoY moves for Change in Taxes: up 106.13% in 2019, down 101.37% in 2019.
- Over 3 years, Change in Taxes stood at $500000.0 in 2018, then tumbled by 101.37% to -$6866.0 in 2019, then rose by 27.18% to -$5000.0 in 2020.
- According to Business Quant data, Change in Taxes over the past three periods registered -$5000.0, $505616.0, and -$6866.0 for Q4 2020, Q3 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -5,000.00 |
| Dec 31, 2020 | -5,000.00 |
| Sep 30, 2020 | 505,616.00 |
| Sep 30, 2020 | 505,616.00 |
| Dec 31, 2019 | -6,866.00 |
| Dec 31, 2019 | -6,866.00 |
| Jun 30, 2019 | 500,617.00 |
| Jun 30, 2019 | 500,617.00 |
| Mar 31, 2019 | 6,249.00 |
| Mar 31, 2019 | 6,249.00 |
| Dec 31, 2018 | 500,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Mar 31, 2018 | -102,000.00 |
| Mar 31, 2018 | -102,000.00 |